Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Drug Trials Snapshot: IMAAVY
IMAAVY (nipocalimab‑aahu) received FDA approval on April 29, 2025 for generalized myasthenia gravis in patients 12 years and older with AChR or MuSK antibodies. In a pivotal 24‑week Phase III trial of 196 adults, the drug achieved a statistically significant 1.5‑point improvement in MG‑ADL scores versus placebo (p=0.002) and a 2.1‑point gain in QMG scores (p<0.001). The regimen involves a weight‑based IV loading dose followed by bi‑weekly maintenance infusions. Safety data showed higher rates of infections, peripheral edema and muscle spasm, but overall tolerability was comparable to placebo.
The $5B Test: Why Healthcare Compliance Programs Keep Failing the Same Way
In fiscal year 2025 the U.S. government recovered a record $6.8 billion under the False Claims Act, with $5.7 billion stemming from healthcare fraud. Despite mandatory compliance programs, many are built to pass audits rather than change behavior, leading to a surge...
MPM Has Collected Three China Drugs for Its ‘Best of Both Worlds’ Strategy
MPM BioImpact, a biotech investment firm, has finalized the acquisition of three China‑origin drug candidates as part of its "best of both worlds" strategy. The deals were brokered through its portfolio company K2 Therapeutics, which now controls three distinct programs...
Scientists Invented a Chewing Gum That Might Help Fight Cancer Some Day
Scientists at the University of Pennsylvania have engineered an antimicrobial chewing gum from lablab bean protein FRIL that dramatically reduces oral cancer‑associated microbes. Ex vivo tests showed a 93 percent drop in HPV levels and near‑zero counts of Porphyromonas gingivalis and Fusobacterium...
Hospital Patients Can Now View Appointments in NHS App
Hospital patients at every acute NHS trust in England can now view, reschedule or cancel referrals and appointments through the NHS App, covering about 64% of all hospital bookings. The rollout adds to the 41 million registered users, with 15 million logins...
Call to Assess, Prescribe and Promote Physical Activity in Clinical Practice: Building on the ACTIVATE Consensus
The British Journal of Sports Medicine published an editorial describing the ACTIVATE consensus, a set of evidence‑based recommendations created by 27 experts from 13 countries to embed physical‑activity assessment, prescription and promotion into routine care for patients with non‑communicable diseases....
ACTIVATE: Physical Activity Assessment, Prescription and Promotion in Clinical Practice by Healthcare Professionals - a Consensus Study Initiated by the...
The International Federation of Sports Physical Therapy launched the ACTIVATE consensus to standardize how clinicians assess, prescribe, and promote physical activity for patients with non‑communicable diseases. A panel of 27 experts from 13 countries, including three patient representatives, used surveys,...
Were One for All: The 6th World Congress of Sport Physiotherapy
The 6th World Congress of Sport Physiotherapy (WCSPT) returns to Bern, Switzerland on 4‑5 December 2026 at the new Bernexpo centre. Organized by the Swiss Sports Physiotherapy Association and IFSPT, the event will feature 42 speakers from 21 nations and a two‑day...
Arcade Game Distraction Makes Kids' Vaccinations Painless
Distraction can soothe the experience of so many medical procedures, especially for kids. This video from a Chinese physician shows how he could give the child two vaccines while he was playing with an arcade game. I'd love to use the same...
Sheffield’s New Cancer Robot Cuts Its Own Ribbon
Sheffield Hospitals Charity donated a record £1.45 million (about $1.84 million) to install a dual‑console da Vinci Xi surgical robot at Northern General Hospital. The system enables surgeons to perform minimally invasive procedures on lung, oesophageal, stomach, bowel, liver, pancreas and kidney...
The Strategic Investments Expanding CDMO Capabilities for HPAPIs and ADCs
Contract development and manufacturing organisations (CDMOs) are accelerating investments to meet soaring demand for highly potent active pharmaceutical ingredients (HPAPIs) and antibody‑drug conjugates (ADCs). The focus is on backward integration, high‑containment infrastructure, and advanced processing such as chromatography and lyophilisation...
FDA Accuses ChemoCentryx of Trial Manipulation in Amgen‑Owned Tavneos Approval
The U.S. Food and Drug Administration has formally accused ChemoCentryx of manipulating results from the pivotal trial that secured approval of its drug Tavneos, now under Amgen’s ownership. The agency says the alleged misconduct could prompt a withdrawal of the...
New Children’s Minnesota COO Lays Out Priority List
John Harding, EdD, began his tenure as executive vice president and chief operating officer of Children’s Minnesota on April 27. Harding arrives from Riley Children’s Health after serving as COO at several pediatric systems, including Children’s Hospital of The King’s...
Designing with Empathy: Writing Content for NHS Lung Cancer Screening
NHS England is piloting a digital version of its lung health check, a key step toward a national lung cancer screening programme slated for rollout by 2030. Over 80 users aged 50‑74 were interviewed, revealing that the word “cancer” triggers...
Start Here: What Is System C?
The blog outlines a new “System C” framework that aims to align food and healthcare around human health outcomes, targeting the $9 trillion blind spot created by chronic disease. It argues that current food (System B) and healthcare systems are optimized...
Should Canada Extend MAID to People with Mental Illness?
Canada’s Bill C-7, passed in 2021, eliminated the natural‑death prerequisite for medical assistance in dying (MAID) but barred individuals whose sole condition is a mental illness. The exclusion was slated to expire after two years, yet Parliament postponed it first...
International News in Brief: IVF Pregnancy Achieved with “Fully Autonomous” System, Prince Edward Island AVT Pilot, Amazon Weight Management Programme
A health‑tech startup, BAIBYS, announced a first‑trimester pregnancy achieved with its fully autonomous AI‑driven system that selects and isolates sperm cells for IVF, cutting procedure time dramatically. In Canada, Prince Edward Island joins a national AI‑scribe pilot that promises clinicians...
14% of New Jersey ACA Enrollees Drop Coverage, Turning to Short‑Term Plans
Around 440,000 New Jersey residents—about 14% of ACA marketplace enrollees—have canceled their coverage after premium tax credits expired, according to Jae Oh. The loss is driving many to consider short‑term health plans, a less regulated alternative that offers limited protections...
FDA Review Lags Keep Terminally Ill Children Waiting for Life‑Saving Drugs
Parents of children with rare, terminal diseases allege the FDA’s slow approval process is denying them life‑saving treatments. Caregivers cite broken promises from FDA leadership and demand faster, risk‑aware pathways as lawmakers push for broader early‑diagnosis reforms.
A Quarter of Healthcare Organizations Report Medical Device Cyber-Attacks
RunSafe Security’s 2026 Medical Device Cybersecurity Index found that 24% of healthcare organizations experienced cyber‑attacks on medical devices in the past year. In 80% of those incidents, the impact on patients was moderate or significant, ranging from delayed imaging to...
AstraZeneca Q1 Profit Jumps 5% on Oncology, Rare‑Disease Gains
AstraZeneca posted a first‑quarter profit of $3.081 billion, a 5.5% rise year‑over‑year, as revenue climbed 12.5% to $15.288 billion. The boost came from strong sales of its oncology and rare‑disease medicines, and the company now faces pivotal FDA decisions on its cancer...
We Detected Aids Through a Federal Early Warning System. Trump Has Decimated It | Robert B Shpiner
The Biden administration has terminated members of the National Science Board, undermining the independence of the National Science Foundation’s $9 bn research portfolio. Simultaneously, the CDC has halted 38 of its 82 surveillance databases—most of them vaccine‑related—and the Advisory Committee on...
Which Supply Chains Are Most Exposed by Disruptions in The Strait of Hormuz?
Jeff Golfman, founder of Send 123, warns that disruptions in the Strait of Hormuz expose a wider contraction in global supply chains, affecting not only oil but also critical medicines. The narrow waterway, a key conduit for cargo from India, Pakistan,...
Could This Be the First Parkinson's Disease Modifier?
In this brief episode, the host and a GAIN representative discuss GT02287, a novel allosteric modulator targeting the glucocerebrosidase (GCase) enzyme, as a potential disease‑modifying therapy for Parkinson’s disease. They explain how the drug stabilizes the misfolded enzyme’s shape, enhancing...
The Exeter Pays £71m as Health Claims Surge
The Exeter paid out roughly $90 million in claims for 2025, with health insurance accounting for about $66 million of that total. Over 16,500 new health‑related claims were recorded, driven mainly by musculoskeletal, connective‑tissue and cancer conditions. Income‑protection payouts rose 12% to...
Arcera and Fosun Sign MoU for Neuroscience Innovation
Arcera Life Sciences and Fosun Pharma have signed a memorandum of understanding to create a long‑term strategic partnership focused on licensing, technology sharing, and neuroscience innovation. The deal taps Fosun’s research and manufacturing capabilities and Arcera’s access to international markets,...
Contextual Determinants of the Implementation of a Mental Health Diversion Policy in California
In 2018 California enacted Assembly Bill 1810, establishing a pre‑trial diversion pathway for defendants with mental health disorders. Implementation is delegated to counties, which have discretion over infrastructure, oversight, and procedural details. A RAND‑sponsored qualitative study interviewed 29 partners across...
RFK Jr. Talked About 'Reparenting' Kids on Wellness Farms. We Visit One that Inspired Him
U.S. Health Secretary Robert F. Kennedy Jr. is promoting a national network of “wellness farms” that would “reparent” children, especially Black youth, by modeling Italy’s San Patrignano community. He cited the Italian abstinence‑based program as a template during his 2024 presidential campaign and reiterated...
How AI Could Help Combat Antibiotic Resistance
Antibiotic resistance now kills over a million people annually and could claim 40 million lives by 2050. Traditional culture‑based diagnostics take days, forcing physicians to guess treatments and driving misuse of antibiotics. AI‑powered diagnostics are achieving more than 99% accuracy and...
Pediatric Dental Surgeries in Children with Intellectual Disabilities and Autism Paid by Means of Medicaid
The study examined Medicaid claims from 2016‑2020 across 40 states, covering 601,286 outpatient dental surgeries for children ages 1‑18 with intellectual disabilities and related conditions (IDRC) and autism. Regression‑adjusted analysis showed that children with IDRC were 14 percentage points less...
Quantum Algorithm Generates Valid KRAS Inhibitor Hits
Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors 👉 “We introduce a quantum–classical generative model for small-molecule design… his work showcases the potential of quantum computing to generate experimentally validated hits that compare favorably against classical models. @biogerontology https://t.co/s7LjNpu2CP
ONC Secures $20M for Huahi's Hexavalent Trispecific
If you're wondering what $ONC got for its $20 m, here's the #AACR25 detail on Huahi's HH160, a symmetrical hexavalent trispecific anti PD-1 x CTLA-4 x VEGF-A MAb https://t.co/Y0jVjTuMMo
Health Care Access and Quality for New York Veterans Provided by the U.S. Department of Veterans Affairs and Community Care
The U.S. Department of Veterans Affairs is proposing to broaden eligibility for its Community Care program, allowing more New York veterans to receive VA‑funded treatment from private providers when VA facilities fall short on access or quality. Currently, only 47%...
Health Care Access and Quality for New York Veterans Provided by the U.S. Department of Veterans Affairs and Community Care
RAND released Volume II of its study on health‑care access and quality for New York veterans under the U.S. Department of Veterans Affairs (VA) Community Care program. The supplement details the research methods, data sources, and analytic techniques used to evaluate...
Health Care Access and Quality for New York Veterans
Around 315,000 New York veterans are enrolled in VA health benefits, but geographic access is limited—only 47% live within a 30‑minute drive of a VA facility and 54% are beyond that range for mental‑health services. The VA Community Care Network (CCN)...
Massive Bio Partners with OpenAI to Broaden Clinical Trial Access
Massive Bio has teamed up with OpenAI under the Impact Hours programme to automate clinical‑trial eligibility screening. The AI engine translates complex sponsor criteria into machine‑readable parameters, enabling real‑time, automated patient pre‑screening for oncology and haematology studies. The partnership includes...
Rocket to Sell PRV for $180m to Advance Gene Therapy Pipeline
Rocket Pharmaceuticals has agreed to sell its rare‑pediatric disease priority review voucher for $180 million after the FDA granted accelerated approval for its Kresladi gene therapy. The voucher, issued for addressing a rare paediatric condition, can be used to speed up...
Health Security Depends on Africa-Europe Cooperation
The World Health Summit Regional Meeting in Nairobi highlighted a decisive shift toward Africa‑Europe health cooperation, moving from pandemic diagnosis to concrete implementation. Both continents are expanding vaccine manufacturing, laboratory networks, and joint research to reduce reliance on external supplies....
Radiologists Implore HHS to Punish Payers Who Undermine Surprise-Billing Protections
More than 100 specialty societies, led by radiology groups, wrote to the U.S. Health and Human Services, Labor and Treasury departments urging stricter enforcement of the No Surprises Act. They allege insurers are sidestepping the law by shifting costs to...
CAR-T Cell Therapies Going in Vivo
Ex‑vivo CAR‑T therapies have saved tens of thousands of patients, but the industry is now pivoting to in‑vivo approaches that can be administered off‑the‑shelf. Over the past year, major pharma players have poured billions into in‑vivo CAR‑T platforms, highlighted by...
Interventional Radiology Group Inks 2 More Practice Partnerships with Urologists
Interventional radiology platform IR Centers announced two new partnerships with urology groups—New Jersey Urology and Orange County Urology Associates—extending its footprint to the Northeast and Southern California. The collaborations will launch multi‑site, image‑guided therapy centers beginning in 2026, offering embolization...
Tumor/Lymph Node Dual‐Targeting Ultrasonic Nanoconverter Orchestrates Spatiotemporal ROS Regulation for Dual‐Zone Programmed Sono‐STING Immunotherapy
Researchers have engineered a dual‑targeting ultrasonic nanoconverter (OPD@PSF) that co‑delivers the sonosensitizer protoporphyrin IX and the STING agonist Vadimezan to breast tumors and their draining lymph nodes. High‑power ultrasound at the tumor site generates abundant reactive oxygen species, inducing immunogenic...
The Need for More Therapists: High Demand, AI, and Career Flexibility
Licensed Independent Clinical Social Worker Liza Brackbill launched Pathways and Possibilities Counseling Services, highlighting a surge in demand for psychotherapy, especially for anxiety‑related disorders, after the COVID‑19 pandemic. She notes that social‑media pressures and heightened awareness have expanded the client...
Gill’s Questions Won’t Shift Reproductive‑rights Opinions
Wow. Who could not want to re-evaluate their stance on abortkon - otherwise known as "reproductive rights" after Congressman Brandon Gill's questions.
Addressing Racial and Ethnic Health Disparities: Insights From the 2026 Commonwealth Fund Report
The Commonwealth Fund’s 2026 State Health Disparities Report shows racial and ethnic gaps in access, quality and outcomes exist in every U.S. state. The data, reflecting system performance through 2024, warn that recent policy shifts—such as Medicaid funding cuts and...
Bevey Miner, Consensus Cloud Solutions
Bevey Miner, EVP of Healthcare Strategy at Consensus Cloud Solutions, explained that digital cloud faxing isn’t the interoperability problem—unstructured fax data is. The company’s eFax platform now includes an AI‑driven extraction engine called Clarity, which converts PDFs, TIFFs and scanned...
Skyn Launches ‘World’s Thinnest’ Non-Latex Condoms
LifeStyles Healthcare Australia introduced Skyn Supreme Feel, a polyisoprene condom touted as the world’s thinnest non‑latex option. The product uses a patented synthetic material that is latex‑free, soft, and stretchy, and it has undergone clinical testing against top latex ultra‑thin condoms....
The Resurrectionists: Grave Robbers Who Built Modern Medicine
In 18th‑ and 19th‑century Britain, illegal grave‑robbing gangs called Resurrectionists supplied fresh cadavers to anatomy schools, filling a critical shortage for medical training. Their organized operations could harvest up to six bodies a night, with a single corpse fetching as...
Surviving VA Slashes: Home Care Providers Report Rate Cut Impacts
In November, the U.S. Department of Veterans Affairs slashed reimbursement rates for home health aide and homemaker services, cutting Texas rates by 43% and New Mexico rates by 19%. The reductions have forced providers like Live Well Home Care to stretch...
Word Games: How Moderna Is Selling Its Newest Vaccine without Using the “V” Word
Moderna’s $776 million federal award for a bird‑flu vaccine is under scrutiny after U.S. officials targeted mRNA technology, prompting the company to warn it may halt late‑stage vaccine programs. Simultaneously, Moderna and Merck are advancing an mRNA‑based cancer treatment, which Merck...